Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
about
Perspective on the dynamics of cancer.Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.Effects of nuclear factor‑κB on the uptake of 131iodine and apoptosis of thyroid carcinoma cells.Combination Therapies Targeting HDAC and IKK in Solid Tumors.
P2860
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@ast
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@en
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@nl
type
label
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@ast
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@en
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@nl
prefLabel
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@ast
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@en
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@nl
P2093
P2860
P1433
P1476
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
@en
P2093
Adam Berlinberg
Bryan R Haugen
Hiroyuki Shibata
Kelsey Wuensch
Nikita Pozdeyev
Qiong Zhou
William M Wood
P2860
P304
P356
10.1371/JOURNAL.PONE.0134901
P407
P577
2015-01-01T00:00:00Z